Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascending-Dose, Double-Blind, Placebo-Controlled, Study of Intralesional Fluphenazine Hydrochloride for Psoriasis

NCT00929578 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT00929578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00929578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascending-Dose, Double-Blind, Placebo-Controlled, Study of Intralesional Fluphenazine Hydrochloride for Psoriasis
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
January 31, 2011
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis